Nasdaq
$1.43▲ 0.60%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $37.9MShares out 26.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
6- 10.3Closed26.10.03 10:30SCHEDULE 13D/AOwnership#●●●#●●●
CVRx, Inc.Bullish
The reporting person sold a total of 1,296,750 shares of CVRx common stock between September 29, 2026, and October 2, 2026. The shares were sold at weighted average prices ranging from $1.56 to $2.59 per share.…more
$1.43+0.60%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.21After-hours26.09.22 05:138-KKey event
CVRx, Inc.
CVRx has appointed John Landry as the new Chief Financial Officer. Landry will join the company on October 12, 2026, and will assume the CFO role immediately following the filing of the company's Q3 2026 Form 10-Q, succeeding the outgoing CFO Jared Oasheim.…more
$1.43+0.60%vs prev closeView filingShare - 8.25Overnight26.08.25 09:00SCHEDULE 13DOwnership
CVRx, Inc.
Jorey Chernett, a beneficial owner of over 5.5% of CVRx shares, has formally urged the Board to initiate an immediate sale process to a strategic acquirer. He argues that selling the company to a large medical device firm would maximize the value of the Barostim product and deliver superior returns to shareholders compared to a standalone strategy, while also calling for immediate executive compensation and expense cuts.…more
$1.43+0.60%vs prev closeView filingShare
5 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoAfter-hours26.10.23 05:30#●●●#●●●
CVRx to Report Q3 2026 Financial Results on November 5
Medical device company CVRx will release its financial and operating results for the third quarter of 2026 after the market closes on November 5. The company will also host a conference call to discuss these results with investors.…more
$1.43+0.60%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.29After-hours26.09.30 05:30
●●●●●●●● ●●●●● ●●●●●●
CVRx will present new clinical data and real-world evidence for its Barostim device at the upcoming HFSA Annual Scientific Meeting. While these presentations aim to strengthen clinical support for the product, they do not represent immediate commercial contracts.…more
$1.43+0.60%vs prev close - 9.21After-hours26.09.22 05:08
●●●●●●●● ●●●●● ●●●●●●
Medical device company CVRx has appointed John Landry as its new Chief Financial Officer. He will succeed Jared Oasheim, who will remain with the company for a transition period.…more
$1.43+0.60%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report